PFE stock profile - insider summary

Manage Columns

Name
Date
Title
Total Bought
Total Sold
Updated
IssuerCik
SubKey
netTransacted

Name
Date
Title
Total Bought
Total Sold
Updated
IssuerCik
SubKey
netTransacted

DAMELIO FRANK A

2023/04/30

Senior Vice President

1459672

-122380

2023-04-30

0000078003

0000078003

1337292
DAMELIO FRANK A

2023/04/29

Senior Vice President

1459672

-122380

2023-04-29

0000078003

0000078003

1337292
RINGO WILLIAM R

2023/04/28

Senior Vice President

399255

2023-04-28

0000078003

0000078003

399255
RINGO WILLIAM R

2023/04/27

Senior Vice President

399255

2023-04-27

0000078003

0000078003

399255
RINGO WILLIAM R

2023/04/26

Senior Vice President

399255

2023-04-26

0000078003

0000078003

399255
RINGO WILLIAM R

2023/04/25

Senior Vice President

399255

2023-04-25

0000078003

0000078003

399255
RINGO WILLIAM R

2023/04/24

Senior Vice President

399255

2023-04-24

0000078003

0000078003

399255
RINGO WILLIAM R

2023/04/23

Senior Vice President

399255

2023-04-23

0000078003

0000078003

399255
DAMELIO FRANK A

2023/04/22

Senior Vice President

1459672

-122380

2023-04-22

0000078003

0000078003

1337292
DAMELIO FRANK A

2023/04/21

Senior Vice President

1459672

-122380

2023-04-21

0000078003

0000078003

1337292

1 2 3 4 5 6 7 8 9 10

PFE stock profile - insider summary

Related News

Adobe Stock Falls Despite Strong Q3 Performance – Is This a Buying Opportunity for Investors?

Nvidia (NASDAQ: NVDA) Stock: AI and Data Center Growth Make It a Must-Buy Despite 140% YTD Rally

Datadog (NASDAQ: DDOG): AI Expansion Powers Revenue Growth, But Is the Stock Still a Buy?

JPMorgan Chase (NYSE: JPM) Stock: A Smart Buy After Recent Pullback?

IBM (NASDAQ: IBM) Takes Off as AI and Cloud Strategy Hit Full Speed

Dell 70% Upside Potential (NASDAQ: DELL) Positioned for Explosive Growth Amid AI Surge and S&P 500 Inclusion

News on the web

PFE Earnings: Pfizer Blows Past Estimates in Q2

Down 60% in 3 Years, Will Moderna Stock (NASDAQ:MRNA) Fall Further?

Pfizer Sets Sight on Obesity Market with Weight Loss Pill

Pfizer (NYSE:PFE) Trends Higher on Mixed Q4 Print

Options Volatility and Implied Earnings Moves Today, January 30, 2024

M & A News: Suave Brands Acquires Haleon’s (NYSE:HLN) ChapStick in $510M Deal

GLP-1 Anti-Obesity Drugs: Slim Waistlines, Fat Profits

Ex-Dividend Date Nearing for These 10 Stocks – Week of January 22, 2024

M & A News: GSK (NYSE:GSK) Offloads Partial Stake in Haleon for $1.2B

M & A News: Pfizer (NYSE:PFE) to Seal $43B Seagen Deal, Analyst Remains Upbeat

Goldman Sachs Says These 3 Healthcare Giants Look Very Attractive Right Now

Pfizer (NYSE:PFE) Little Changed as White House Pursues Drug Patents

Pfizer (NYSE:PFE) Slides as Weight Loss Drug Suffers Setback

Biden Plans to Boost Drug Production Using Cold-War Era Law

Pfizer (NYSE:PFE) Sued Re:Low-Quality ADHD Drug for Kids

Pfizer (NYSE:PFE) to Layoff 500 Workers at UK Site

Ex-Dividend Date Nearing for These 10 Stocks – Week of November 6-10, 2023

Pfizer (NYSE:PFE) Delivers Lackluster Q3

Mixed Day for Vaccine Stocks as Terrible News Emerges

Roivant (NASDAQ:ROIV) Gains after Roche’s $7.1 Billion Buy of Televant

Pfizer (NYSE:PFE) Dips as UBS Starts Coverage

Pfizer (NYSE:PFE) Slides despite EU Nod to Seagen Acquisition

Alphabet Stock (NASDAQ:GOOGL) Q3 Earnings Preview: Can Its Strength be Sustained?

LLY vs. PFE: Which Pharma Stock is the Better Buy?

Pfizer (NYSE:PFE) Slips on Drug Price Hikes

Pfizer (NYSE:PFE) Provides FTC with Documents for Seagen Acquisition

Moderna (NASDAQ:MRNA) Slides as COVID-19 Vaccine Sales Confirmed

Pfizer Stock (NYSE:PFE) Down; Waning COVID Sales Hit Guidance

Novavax (NASDAQ:NVAX): Europe Delays Vaccine Approval

BioNTech (NASDAQ: BNTX) Slides After $0.9 Billion Comirnaty Write-Off

Pfizer (NYSE:PFE) Bags Approval for 2 Drugs

Pfizer (NYSE:PFE) Down despite Hefty Number of COVID-19 Shots

Drug Companies Mixed as Medicare Plans to Negotiate

Novavax (NASDAQ:NVAX) Surges Following Success Against COVID-19 Variants

Will BioNTech’s (NASDAQ:BNTX) COVID-19 Vaccine Sales Reaccelerate?

Moderna’s (NASDAQ:MRNA) Updated COVID Vaccine Effective Against Eris Variant